XML 119 R82.htm IDEA: XBRL DOCUMENT v3.25.0.1
Employee Benefit Plans and Stock-based Compensation - Performance Shares (Details) - USD ($)
$ / shares in Units, $ in Millions
1 Months Ended 12 Months Ended
Feb. 18, 2025
Feb. 20, 2024
Mar. 15, 2023
Feb. 14, 2023
Mar. 14, 2022
Feb. 15, 2022
Feb. 17, 2021
Mar. 31, 2023
Feb. 28, 2022
Feb. 28, 2021
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Performance Shares                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares                          
Non-vested, beginning of period (in shares)                     38,000 76,000  
Granted (in shares)                     301,000 13,000  
Vested (in shares)                     (38,000) (38,000)  
Forfeited (in shares)                       (13,000)  
Non-vested, end of period (in shares)                     301,000 38,000 76,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Non-vested, beginning of period (in dollars per share)                     $ 15.37 $ 15.37  
Granted (in dollars per share)                     2.28 3.71  
Vested (in dollars per share)                     15.37 15.37  
Forfeited (in dollars per share)                       3.71  
Non-vested, end of period (in dollars per share)                     $ 2.28 $ 15.37 $ 15.37
Weighted-average grant date fair value of stock options granted (in dollars per share)               $ 3.71 $ 7.83 $ 15.37      
Percentage of performance target cap of award   100.00% 100.00%                    
Percentage of year-over-year annual revenue growth rate       2.70% 44.00%                
Shares eligible to vest   0   0                  
Percentage of targeted financial performance                     200.00%   150.00%
Unrecognized compensation expense related to restricted stock awards                     $ 0.3    
Weighted-average remaining contractual terms                     1 year 10 months 24 days    
Performance Shares | Subsequent Event                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Percentage of year-over-year annual revenue growth rate 200.00%                        
Performance Shares | Minimum | Scenario Performance Financial Metric Less Than 50%                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Percentage of targeted financial performance           50.00%              
Performance Shares | Minimum | Scenario Performance Financial Metric is Between 50% to 200%                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Percentage of targeted financial performance           50.00%              
Performance Shares | Maximum | Scenario Performance Financial Metric is Between 50% to 200%                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Percentage of targeted financial performance           200.00%              
Performance Shares | Maximum | Scenario Performance Financial Metric Greater Than 200%                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Percentage of targeted financial performance           200.00%              
Performance Shares | Share-Based Payment Arrangement, Tranche One                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares                          
Vested (in shares)                     0    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Vesting period                     4 years    
Performance Shares | Chief Executive Officer                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Stock options grants in period   223,590 223,590       113,130            
Performance Shares | Chief Executive Officer | Scenario Performance Minimum Financial Metric                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Share options vested in period   223,590 223,590                    
Performance Shares | Chief Executive Officer | Scenario Performance Financial Metric Less Than 50%                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Stock options grants in period           114,320              
Performance Shares | Chief Executive Officer | Scenario Performance Financial Metric is Between 50% to 200%                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Stock options grants in period           114,320              
Performance Shares | Chief Executive Officer | Scenario Performance Financial Metric Greater Than 200%                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Stock options grants in period           114,320              
Performance Shares | Chief Financial Officer                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Stock options grants in period   77,600 77,600       38,475            
Performance Shares | Chief Financial Officer | Scenario Performance Minimum Financial Metric                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Share options vested in period   77,600 77,600                    
Performance Shares | Chief Financial Officer | Scenario Performance Financial Metric Less Than 50%                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Stock options grants in period           32,100              
Performance Shares | Chief Financial Officer | Scenario Performance Financial Metric is Between 50% to 200%                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Stock options grants in period           32,100              
Performance Shares | Chief Financial Officer | Scenario Performance Financial Metric Greater Than 200%                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Stock options grants in period           32,100              
Employee Stock Option                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value                          
Stock options grants in period                     0 0 0